OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
October 06, 2023
Biosynth has further strengthened its peptide division with the acquisition of Pepceuticals.
Webinar Date/Time: Mon, Oct 30, 2023 11:00 AM EDT
October 05, 2023
With the acquisition, Sharp plans on offering fully integrated small-to-medium scale sterile injectable services.
October 02, 2023
The newly established business under Advent International and Warburg Pincus will be named Simtra BioPharma Solutions.
September 29, 2023
Webinar Date/Time: Mon, Oct 23, 2023 11:00 AM EDT
Dosage forms are being shaped by numerous factors, with patient-centricity continuing to be an important driver of decisions in development.
Twin-screw granulation process insight is growing as researchers employ new analytical technologies and investigate new ways to use the equipment.
September 28, 2023
With the two new GMP-grade mRNA manufacturing sites in Germany, MilliporeSigma can now offer fully integrated mRNA services.
September 26, 2023
Under a new pact, Genentech and PeptiDream will collaborate to discover and develop novel peptide-radioisotope drug conjugates.
September 25, 2023
The Novo Nordisk Foundation will invest up to DKK 950 million (€127 million, US$136 million) in a new cell therapy manufacturing facility in Lyngby, Denmark.